Metabolic phenotyping of tear fluid as a prognostic tool for personalised medicine exemplified by T2DM patients.

Authors:
Brunmair J; Bileck A; Schmidl D; Hagn G; Meier-Menches SM and 4 more

Journal:
EPMA J

Publication Year: 2022

DOI:
10.1007/s13167-022-00272-7

PMCID:
PMC8897537

PMID:
35265228

Journal Information

Full Title: EPMA J

Abbreviation: EPMA J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalThis study was approved by the ethical committee of the Medical University Vienna. Consent to participateVolunteers have given their written, informed consent to participate in this study. Consent for publicationVolunteers have given their written, informed consent for publishing the data. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding Open access funding provided by University of Vienna. This study was supported by the Austrian Science Foundation (FWF Project No. KLI 721)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025